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DMPGApolipophorin III (apoLp-III) from Locusta migratoria was used as a model to investigate apolipoprotein lipid
binding interactions. ApoLp-III contains eight lysine residues, of which seven are located on one side of the
protein. To investigate the role of positive charges on lipid binding, lysine residues were acetylated by acetic
anhydride. The degree of acetylation was analyzed by SDS-PAGE and MALDI-TOF, indicating a maximum of
eight acetyl additions. Modiﬁed apoLp-III remained α-helical, but displayed a decreased α-helical content
(from 78 to 54%). Acetylation resulted in a slight increase in protein stability, as indicated by a change in the
midpoint of guanidine–HCl induced denaturation from 0.55 (unmodiﬁed) to 0.65 M (acetylated apoLp-III).
Lipid bound apoLp-III, either acetylated or unmodiﬁed, displayed similar increases in helical content and
midpoint of guanidine–HCl-induced denaturation of ∼4 M. The ability to solubilize vesicles of
dimyristoylphosphatidylcholine remained unchanged. However, the rate to solubilize dimyristoylpho-
sphatidylglycerol vesicles was reduced two-fold. In addition, a decreased ability to stabilize diacylglycerol-
enriched low density lipoproteins was observed. This indicated that lysine residues are not critical for the
protein's ability to bind to zwitterionic phospholipids. Since binding interactions with ionic phospholipids
and lipoproteins were affected by acetylation, lysine side-chains may play a modulating role in the
interaction with more complex lipid surfaces encountered in vivo.© 2009 Elsevier B.V. All rights reserved.1. Introduction
Apolipophorin III (apoLp-III) is a key component of a remarkable
lipid transport system, present in a number of insect species. During
ﬂight, low density lipophorin is employed to shuttle large amounts
of diacylglycerol (DG) from fat body triacylglycerol (TG) reserves to
the energy consuming ﬂight muscles [1]. In this process, DG
associates with existing lipophorin particles, which are stabilized
by association of apoLp-III. Upon DG delivery and hydrolysis, apoLp-
III dissociates from the lipophorin surface and can be reused. This
transport system enables the insect to mobilize large amounts of
stored fat reserves during strenuous exercise such as prolonged
ﬂight. ApoLp-III is found in several insect orders, most notably in
Lepidoptera and Orthoptera [2]. The globular protein, approximately
18 kDa in size, shares important structural features with mamma-
lian apolipoproteins [3–5], and is comprised of a bundle of
amphipathic α-helices. In the lipid-free state, as shown by X-ray
and NMR solution structures, the protein's ﬁve α-helices are folded
in an up-and-down topology [6–8]. Hydrophobic residues are buried
inside the protein interior, while polar and charged residues are
located on the protein surface. Upon lipid binding, the ﬂexible
protein undergoes a large conformational change. During this
process the interior is exposed, allowing hydrophobic amino acid+1 562 985 8557.
ll rights reserved.side-chains to gain direct access to the lipid surface [9–11]. The
relative low protein stability of apoLp-III favors helix bundle
opening and exposure of the hydrophobic interior, thereby facilitat-
ing lipid binding [7,8,12]. On the other hand, polar and charged
amino acid residues reside on the protein surface and are exposed
to the aqueous solvent and maintain apolipoprotein solubility and
integrity. Potentially, these residues may be involved in binding
interactions with the non-exchangeable apoLp-I/-II found in
lipophorin or cell surface binding sites as shown for the N-terminal
domain of human apoE [13]. Moreover, apolipoprotein lipid binding
interactions may require charged residues, as superﬁcial insertion in
the phospholipid surface potentially involves contacts with phos-
phatidyl headgroups. To address this, positively charged ɛ-amino
groups of lysine side-chains were targeted for acetylation. A
previous study showed that modiﬁcation of the 23 lysine residues
present in Manduca sexta apoLp-III (166 residues total) resulted in a
complete loss of secondary structure, preventing functional analysis
[14]. However, apoLp-III from Locusta migratoria bears only eight
lysine residues, and may therefore be a more suitable candidate to
investigate the role of lysine residues in apolipoprotein lipid
binding. In the present study, L. migratoria apoLp-III was acetylated,
and analyzed for secondary structure. Subsequently, the lipid
binding properties were investigated using model bilayer vesicles
of either zwitterionic or negatively charged phospholipids. In
addition, lipoprotein binding was analyzed using DG-enriched low
density lipoproteins.
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2.1. Protein expression, puriﬁcation and modiﬁcation
Recombinant apoLp-III was expressed in E. coli BL21 (DE3+) cells
in minimal medium as previously reported, and lacks the carbohy-
drate chains normally present in native apoLp-III [15]. Protein
expression was induced with isopropyl-β-D-thiogalactopyranoside
(1 mM ﬁnal concentration) after the optical density of the bacterial
culture reached a value of 0.6. Four hours later, cells were removed
by centrifugation, and the cell-free supernatant concentrated to
20 mL using a 10 k tangential ﬂow concentrator. ApoLp-III was
isolated using a two-step chromatography procedure. First, the
apoLp-III was separated from other proteins and cell debris using a
G-75 gel ﬁltration column (60×2.5 cm). Then the peak containing
apoLp-III was further puriﬁed by reversed-phase HPLC (Beckman
Gold) using a linear gradient of water and acetonitrile in 0.05%
triﬂuorethanol, and a Zorbax C8 semi-preparative column (Agilent
technologies, Santa Clara, CA). Solvent was removed by freeze-
drying and protein samples were stored at−20 °C until further use.
The purity of the preparations was veriﬁed by sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) using precast
4–20% Tris–glycine gels (Invitrogen, Carlsbad, CA). Proteins were
ﬁxed and stained with 0.5% (w/v) naphthol blue black (Sigma-
Aldrich, St. Louis, MO). In addition, proteins were visualized using
2,2,2,-trichloroethanol (TCE, Sigma-Aldrich). Gels were incubated
with 10% TCE (v/v) in water:methanol (1:1, v/v) for 10 min, and
visualized using a UV transilluminator. ApoLp-III (0.5 mg/mL) was
acetylated with acetic anhydride in 2 mL of a saturated sodium
acetate solution [16]. The modiﬁed apoLp-III samples were subse-
quently dialyzed in a 0.15 M NaCl containing 0.1% EDTA (w/v),
followed by dialysis in phosphate buffered saline (PBS; 137mMNaCl,
2.7 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4, pH 7.4). The extent of
the lysine modiﬁcation was veriﬁed by MALDI-TOF (Applied
Biosystems 4800) using sinapinic acid as the matrix.
2.2. Secondary structure analysis
The secondary structure of apoLp-III was analyzed with a Jasco 810
spectropolarimeter using a circular cuvet (pathlength 0.1 cm) and a
protein concentration of 0.2 mg/mL in 10 mM sodium phosphate, pH
7.2. Plots are the average of three scans, measured at a scan rate of
20 nm/min. The ellipticity (θ) was converted into molar ellipticity
using the equation in which MRW is the mean residue weight,
θ=ellipticity in mdeg, l=pathlength in cm, and c=concentration in
mg/mL:
θ½  = MRW  θ
10  l  c deg cm
2 dmol−1: ð1Þ
The α-helical content was assessed with the following equation [17]:
fraction α − helix = − θ½ 222 + 3000
39;000
: ð2Þ
Molecular graphics images were produced using the UCSF Chimera
package from the Resource for Biocomputing, Visualization, and
Informatics at the University of California, San Francisco [18].
2.3. Phospholipid vesicle solubilization
Dimyristoylphosphatidylcholine (DMPC) and dimyristoylpho-
sphatidylglycerol (DMPG) were obtained from Avanti Polar Lipids.
Multilamellar vesicles were obtained by vigorously vortexing a dried
lipid ﬁlm with 1 ml of PBS at 30 °C [12]. Small unilamellar vesicles
(SUVs) were obtained by extruding themultilamellar vesicles through
a 200 nm membrane (Avanti mini extruder). To measure the rate ofvesicle solubilization, SUVs were incubated at the lipid crystalline to
liquid gel-state transition temperature (TM), i.e. 24 °C for DMPC and
23 °C for DMPG. To a dispersion of 250 μg DMPC vesicles, equilibrated
at the TM for 10 min, 250 μg apoLp-III was added. In studies using
DMPG vesicles, 250 μg of lipid was incubated with 25 μg of apoLp-III.
The decrease in light scatter, a result from conversion of SUVs into
small discoidal protein–lipid complexes, was monitored by the
absorption at 325 nm in a Shimadzu spectrophotometer (UV-
2401PC) equipped with a Peltier unit. Assuming ﬁrst order reaction
kinetics, rate constants were calculated from the initial slopes. For
secondary structure and electron microscopic analysis, excess lipid-
free apoLp-III was removed by Superdex-200 gel ﬁltration chromato-
graphy. The formation of nanodisks was veriﬁed by transmission
electron microscopy, using a Joel JEM 1200 EX-11 operated at 100 kV.
Samples were negatively stained using phosphotungsten.
2.4. Lipoprotein binding
To measure apoLp-III binding to lipoproteins, a 200 μl solution of
human low density lipoprotein (LDL, 50 μg protein; Sigma-Aldrich) in
buffer (150 mM NaCl, 2 mM CaCl2, 50 mM Tris–HCl, pH 7.4) was
incubated in the absence or presence of 2 mU phospholipase-C
(Sigma-Aldrich) [19]. PL-C-induced aggregation was measured by the
absorbance at 340 nm in a microplate reader (Thermo Labsystems,
Helsinki, Finland). The ability of apoLp-III to protect LDL from
aggregation was measured by including μg quantities of apoLp-III in
the reaction mixture, taking sample turbidity readings at the speciﬁed
times.
3. Results
3.1. ApoLp-III lysine modiﬁcation and characterization
ApoLp-III contains eight lysine residues at positions 52, 54, 63, 68
(helix-2); 121 (helix 4); and 143, 145, and 161 (helix-5). The lysine
residues are evenly distributed on the protein surface although seven
are located on one side of the protein, more or less formed by helix 2, 3
and 5 (Fig. 1). To neutralize the ɛ-amino groups of the lysine side-
chains, the protein was acetylated with acetic anhydride. SDS-PAGE
analysis showed that the apoLp-III samples treated with acetic
anhydride migrated at a slower rate compared to untreated protein.
Since the naphthol blue black protein staining was signiﬁcantly
reduced for the acetic anhydride-treated protein samples, gels were
treated with TCE to increase the staining intensity. TCE adds a formyl
group to tryptophan residues, resulting into a large red-shift in the
ﬂuorescence emissionmaximum into the visible range [20]. As seen in
Fig. 2A, apoLp-III was visualized effectively by TCE, and displayed a
decreased electrophoretic mobility upon treatment with acetic
anhydride compared to unmodiﬁed apoLp-III. This indicated a
substantial number of the apoLp-III lysine residues were acetylated.
To determine the extent of acetylation in more detail, the proteins
were analyzed by mass spectrometry. The MALDI-TOF mass spectrum
for acetylated (Ac)-apoLp-III displayed two major peaks with
molecular masses of 17,618 and 17,661 Da (Fig. 2B). Unmodiﬁed
apoLp-III produced a molecular mass of 17,321 Da, close to the
calculated mass of 17,327 Da based on the amino acid sequence (not
shown). Thus, the mass of acetylated protein increased by 297 or
340 Da, respectively. This corresponded with the addition of seven or
eight acetyl groups assuming 42 Da per lysine acetylation.
3.2. Secondary structure analysis
To assess potential structural changes of apoLp-III as a result of
lysine acetylation, the secondary structure of Ac-apoLp-III was
analyzed by circular dichroism. Far-UV CD spectra showed that the
protein retained its α-helical character with troughs at 208 and
Fig. 1. ApoLp-III high resolution structure. Surface contour of apoLp-III (PDB 1AEP) from the front (panel A) or back (panel B) indicating lysine residues in blue. Panel C: ribbon
presentation (side-view) with lysine side-chains in blue. Drawings were created using Chimera [18].
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reduced molar ellipticity compared to unmodiﬁed apoLp-III.
Secondary structure calculations revealed that the helical content
was reduced from 78% in unmodiﬁed apoLp-III to 54% for Ac-
apoLp-III. To gain insight into the protein stability properties,
guanidine–HCl was employed as the denaturing agent. The
denaturation proﬁles revealed a slight difference between the
proteins. The midpoint of guanidine–HCl denaturation increased
from 0.55±0.02 M for unmodiﬁed apoLp-III to 0.65±0.03 M
guanidine–HCl for Ac-apoLp-III. Moreover, the slope of the plot was
less steep for Ac-apoLp-III (Fig. 4).
Since the lysine ɛ-amino group may be involved in ionic
interactions with negatively charged moieties on phospholipid head-
groups, a stabilizing effect of the protein in the lipid-bound form may
be anticipated. Therefore, α-helical content and stability were also
determined for apoLp-III/DMPC complexes, termed nanodisks. Far-UV
spectra indicated that both unmodiﬁed and Ac-apoLp-III in the
nanodisks displayed a substantially increased α-helical content
(Table 1). As shown in Fig. 4 (inset), the apoLp-III midpoint of
guanidine–HCl denaturation increased greatly to values of approxi-
mately 4M, in agreement with previous reports [21,22]. For Ac-apoLp-
III a similar increase in protein stability was observed. The denatura-
tion plots of lipid-bound apoLp-III further indicated that the
denaturation was not a simple two state process, with proteins eitherFig. 2. Acetylation of apoLp-III. Proteins were analyzed on 4–20% gradient SDS-PAGE
gels and stained for protein with TCE (panel A). M) molecular weight standards; Lane
1) unmodiﬁed apoLp-III; lane 2) Ac-apoLp-III. Panel B: MALDI-TOF spectrum of Ac-
apoLp-III.in a folded or unfolded state, but that unfolding intermediates may be
present.
3.3. SUV solubilization
The ability of Ac-apoLp-III to interact with phospholipid bilayers
was investigated using DMPC SUVs. Similar to other apolipoproteins,
apoLp-III is able to spontaneously solubilize DMPC SUVs at the
phospholipid TM [23]. Addition of apoLp-III to a dispersion of SUVs
resulted in a steady decrease in light scatter intensity, measured
spectrophotometrically at 325 nm. The change in apparent absor-
bance is the result of decreased light scatter intensity when SUVs
(∼200 nm in diameter) were transformed into much smaller
nanodisks (∼15 nm diameter). The DMPC SUV solubilization rate
induced by Ac-apoLp-III was very similar to that of unmodiﬁed
apoLp-III (Fig. 5A). Assuming a 1st order reaction, a rate constant of
0.27±0.05 min−1 for unmodiﬁed apoLp-III and 0.26±0.06 min−1
for Ac-apoLp-III was obtained. Transmission electron microscopy
analysis of the newly formed nanodisks showed no differences
between Ac-apoLp-III and unmodiﬁed apoLp-III (not shown). To
further analyze the effect of charge, negatively charged DMPG vesicles
were employed. The solubilization rates with DMPG are an order of
magnitude faster compared toDMPC, therefore a 10 fold lesser amount
of apoLp-IIIwas used to obtainmeasurable rates. In this case, the ability
to solubilize DMPG SUVs was signiﬁcantly reduced for Ac-apoLp-III
(Fig. 5B). The rate constants of this transformation, 0.91±0.28 min−1
for unmodiﬁed apoLp-III and 0.39±0.04 min−1 for Ac-apoLp-III,
showed a 2-fold decrease for the acetylated protein.Fig. 3. Secondary structure analysis. FAR UV CD spectra of apoLp-III (solid line) and Ac-
apoLp-III (dashed line).
Fig. 4. Gdn–HCl denaturation proﬁles of apoLp-III and Ac-apoLp-III. Unmodiﬁed apoLp-
III (closed circles) and Ac-apoLp-III (open circles) are shown in the lipid-free state
(main ﬁgure) and lipid-bound state (inset).
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The effect of apoLp-III acetylation on lipoprotein binding interac-
tion was analyzed using modiﬁed LDL. While apoLp-III does not bind
to human LDL as such, it rapidly associates with LDLwhen DG emerges
on the lipoprotein surface. This process mimics the association of
apoLp-III with lipophorin in vivo when large amounts of DG are
transferred from the fat body to insect lipoprotein during prolonged
ﬂight [24]. To create DG on the surface of LDL particles, phospholipase-
C was incubated with LDL, converting phosphatidylcholine into DG
[19]. As a result, modiﬁed LDL forms large aggregates, as is evident by
the rapid increase in sample turbidity measured at 340 nm. However,
DG-enriched LDL recruits apolipoproteins on its surface, thereby
preventing lipoprotein aggregation, and the incubation mixture
remains optically clear. As shown in Fig. 6A, 50 μg of either Ac- or
unmodiﬁed apoLp-III incubated simultaneously with LDL and phos-
pholipase-C prevented lipoprotein aggregation for a period of 50 min.
However, at extended incubation times, Ac-apoLp-III lost its protective
role, as is evident by the onset of sample turbidity. Using limited
amounts of apoLp-III, differences between the two proteins became
more pronounced. While 10 μg of unmodiﬁed apoLp-III remained
effective in providing full protection for a during an incubation time of
60 min, a minimum of 25 μg of Ac-apoLp-III was required to prevent
the onset of phospholipase-C-induced LDL aggregation (Fig. 6B). This
result indicated that the ability of Ac-apoLp-III to bind to the DG-
enriched LDL surface was decreased compared to the unmodiﬁed
protein.
4. Discussion
ApoLp-III is an exchangeable apolipoprotein with a predominantly
hydrophobic interior. Few polar residues are buried, and it is thought
that some of these residues have a destabilizing effect on the proteinTable 1
Properties of Ac- and unmodiﬁed apoLp-III.
Ac-apoLp-III Unmodiﬁed apoLp-III
Molecular mass 17,661 Da 17,327 Da
[Gdn–HCl]1/2 lipid-free 0.65 M 0.55 M
[Gdn–HCl]1/2 DMPC-bound 4.2 M 4.4 M
Helical content 54% 78%
Helical content DMPC-bound 92% 99%
Rate of DMPC transformation 0.26 min−1 0.27 min−1
Rate of DMPG transformation 0.39 min−1 0.91 min−1
LDL protectiona 25 μg 10 μg
a The amount of apoLp-III required to prevent aggregation of 100 μg LDL treated with
2 mU of phospholipase-C during a 60 min incubation at 37 °C.structure. In turn, the reduced stability promotes helix bundle
opening, facilitating binding to lipid surfaces [7,8]. The stability of
apoLp-III is relatively low, as indicated by amidpoint of guanidine–HCl
denaturation of ∼0.6 M [22]. A mutant apoLp-III which was more
stable displayed a decreased ability to solubilize DMPC SUVs [12].
Such an inverse correlation between protein stability and lipid binding
has been reported for human apoE isoforms as well [3,17]. In addition
to hydrophobic forces, electrostatic interactions are expected to play a
signiﬁcant role in apoLp-III lipid binding interaction. Human apoA-I,
apoE and sphinxmoth apoLp-III from M. sexta, Galleria mellonella and
Bombyx mori, are all relatively rich in lysine and arginine residues
(∼15% of total amino acids). On the other hand, apoLp-III from L.
migratoria bears only eight lysine and one arginine residue (∼6%), and
contains two N-linked complex carbohydrate chains [25]. Removal of
carbohydrate does not affect the structural properties, but enhanced
the vesicle solubilization rate to a level comparable with M. sexta
apoLp-III [26]. The role of carbohydrate in locust apoLp-III in vivo
remains unknown, although it may be possible that it maintains the
protein solubility at high concentrations. In the present study, the
positive charges of lysine side-chains were neutralized by acetylation
with acetic anhydride. MALDI-TOF analysis revealed that up to eight
residues were modiﬁed. Besides a decreased electrophoretic mobility
on SDS-PAGE, protein staining of Ac-apoLp-III was signiﬁcantly
reduced, probably because naphthol blue black binding depends in
part on the presence of lysine. Soaking the protein gels with a solution
containing TCE improved the visualization of Ac-apoLp-III substan-
tially. TCE depends directly on the presence of tryptophan residues
(two present in L. migratoria apoLp-III), thus lysine modiﬁcation does
not affect the visualization. Also, protein bands become visible after
only a few minutes [20], while prolonged destaining periods areFig. 5. SUV solubilization. Vesicles of DMPC (panel A) and DMPG (panel B) were
incubated at the phospholipid transition temperature, after the addition of apoLp-III.
The decrease in light scatter was monitored by the absorption at 325 nm. Solid line: no
apoLp-III; dashed line: unmodiﬁed apoLp-III; dotted line: Ac-apoLp-III.
Fig. 6. Protection of apoLp-III to LDL aggregation. Phospholipase-C was used to induce
LDL aggregation, which wasmeasured by the absorbance at 340 nm for 80min (Panel A,
solid line). Incubation of LDL and phospholipase-C in the presence of unmodiﬁed
apoLp-III (dashed line) provided full protection, while the ability of Ac-apoLp-III
(dotted line) to prevent LDL aggregationwas reduced. Panel B: LDL and phospholipase-
C were incubated with μg quantities of apoLp-III to measure the minimum amount of
apoLp-III required to prevent aggregation (measured at 60 min).
1905L.J. Vasquez et al. / Biochimica et Biophysica Acta 1788 (2009) 1901–1906necessary when employing naphthol blue black. This protein dye is
routinely employed to stain L. migratoria apoLp-III on polyacrylamide
gels as themore commonly used Coomassie Brilliant Blue depends too
much on the presence of positively charged residues [27].
Acetylation resulted in a moderate decrease in secondary structure
content, possibly by diminished ionic interactions, but overall the
protein remained α-helical and soluble in buffer. In addition, DMPC
binding induced a substantial increase in helical content. The stability
of Ac-apoLp-III in the lipid-free state was similar to unmodiﬁed
protein. Nevertheless, close inspection of the guanidine–HCl dena-
turation plots revealed a small, yet measurable increase in protein
stability. Also, the slope of the plot was less steep for Ac-apoLp-III,
indicating less cooperativity of unfolding in the absence of ɛ-amino
groups of lysine side-chains, perhaps because of the lack of charge
repulsion between neighboring lysine residues. Similar results were
reported for acetylated apoA-I, although the cooperative effect was
muchmore pronounced in the latter. This may be a reﬂection of the 21
lysine and 16 arginine side-chains present in the 243-residue human
apolipoprotein [28]. Since Ac-apoLp-III retained its helical character
we were able to assess the lipid binding properties. In contrast, lysine
residues carry out a signiﬁcant structural role in M. sexta apoLp-III as
acetylation resulted in a protein almost devoid of secondary structure.
Not surprisingly,M. sexta apoLp-III lipoprotein binding and the ability
to spontaneously form nanodisks at the phospholipid TMwas virtually
absent [14].
The ability to solubilize DMPC vesicles remained unchanged for L.
migratoria Ac-apoLp-III. This indicates that neutralization of lysineside-chains has no effect on the ability of the protein to recognize
potential lipid surface defects and to open its hydrophobic interior to
initiate binding. In this respect, a hydrophobic patch formed by
leucine residues on the apolipoprotein surface may be responsible to
initiate lipid binding as suggested previously [29,30]. It was predicted
that lysine residues participated in ionic interactions with phosphate
moieties of phosphatidylcholine, but the rate of nanodisk formation
was essentially similar for both unmodiﬁed and Ac-apoLp-III.
Furthermore, acetylation of apoLp-III did not result in changes in
protein stability when complexed with DMPC and both modiﬁed and
Ac-apoLp-III showed the distinctive large increase in resistance to
guanidine–HCl induced denaturation in nanodisks. These ﬁndings
indicate that lysine side-chains are not essential for binding to
zwitterionic DMPC vesicles, and are not a signiﬁcant factor for
nanodisk stabilization. Thus, these processes are likely dominated by
hydrophobic forces, while inter-helical contacts between neighboring
apoLp-III molecules may also contribute [31]. The six lysine residues
that reside in the polar–nonpolar interface characterize these
amphipathic α-helices as class A, while the three remaining helices
are class G⁎ [32]. It has been suggested that interfacial lysines are a
crucial part of the snorkel model [33], if so acetylationmay change the
character of these helices. Nevertheless, it is possible that the 4-carbon
aliphatic portion of lysine remains in close contact with the
hydrophobic interior of the phospholipid bilayer, and instead of
charged amino groups, the acetyl moieties point out in the aqueous
environment. Therefore, the hydrophobic face of the helices has not
been changed signiﬁcantly, explaining the unaltered DMPC binding
interaction. Nevertheless, the rate constant for DMPG vesicle
solubilization was decreased by 2-fold upon acetylation, indicating
that a potential role in the binding process of electrostatic attraction
between lysines and negative glycerol headgroups. ApoLp-III associa-
tion to lipoprotein surfaces was assessed with human LDL. Induced by
phospholipase-C catalysis, DG appeared on the LDL surface, triggering
apolipoprotein binding. This elegant assay is particularly relevant for
apoLp-III because it creates DG on the LDL surface. This resembles the
in vivo apoLp-III lipoprotein binding interaction in insect hemolymph,
where up to 16 molecules of apoLp-III associate with DG-enriched
lipophorins to maintain lipoprotein integrity [34,35]. While well
suited for apoLp-III, the assay is also highly applicable to apoA-I and
apoE and illustrates the structural and functional similarity between
these apolipoproteins with amphipathic α-helices as the element
responsible for lipid binding [19,36]. At conditions for which
unmodiﬁed apoLp-III binds to the LDL surface providing full protec-
tion from lipoprotein aggregation, the ability of Ac-apoLp-III to
prevent lipoprotein aggregation was signiﬁcantly reduced. The
observation that Ac-apoLp-III lost in part its protective role indicated
that lysine residues interact to some extent with the LDL surface
through ionic forces. Obviously, the surface of LDL is more complex
compared to SUVs, and harbors apoB100, phosphatidylcholine and
sphingomyelin (66 and 29% of the total lipid mass, respectively) [37].
The conversion of phosphatidylcholine into DG causes major lipid
packing problems, which is resolved by superﬁcial apoLp-III associa-
tion with the LDL surface [38]. As postulated earlier, the amphipathic
α-helices are able to cover the hydrophobic gaps between phospha-
tidylcholine headgroups, when DG intercalates in the phosphatidyl-
choline monolayer [39].
While electrostatic interactions were postulated to be major
forces that direct apoLp-III phospholipid bilayers interaction [40],
the present data with DMPC SUVs does not support this. Monolayer
studies with DG also pointed out that hydrophobic forces may play
a critical role [40,41]. The present study with DMPC bilayers is in
support of the view that such forces are essential for apolipopro-
tein lipid interaction. Nevertheless, electrostatic interactions,
modulated by positively charged lysine side-chains, may contribute
to binding interactions in more complex lipid mixtures encoun-
tered in vivo.
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